What’s in the Parkinson’s Disease Pipeline? Gene and Cell Therapies

Start time
10:00 AM Pacific
End time
11:00 AM Pacific

Presented by Parkinson’s Disease Foundation, as part of their PD ExpertBriefings series

Register Now
Includes complimentary CEUs

Are there new therapies on the horizon to help treat Parkinson’s Disease? In the search for more effective treatments, two promising areas of research are gene therapies and cell therapies. Learn more about the potential of these two types of experimental treatments by joining a one-hour online seminar led by Parkinson’s Disease Foundation and Roger Barker, M.B.B.S, M.R.C.P, Ph.D.

Participants in this web seminar will be able to:

  • Discuss how cell-based therapies for Parkinson’s are designed to replace dopamine cells  lost to the disease;
  • Understand how gene therapies are designed to either rescue dopamine cells or produce     dopamine more efficiently in the brain; and,
  • Understand why neither approach is a cure, but how each might one day offer exciting  ways to help people with Parkinson’s live better and reduce their other medications.


Roger Barker, M.B.B.S, M.R.C.P, Ph.D., is professor of Clinical Neuroscience and honorary consultant, Neurology, University of Cambridge and Addenbrooke’s Hospital in the U.K. In addition to publishing more than 300 papers, he is co-editor in chief of the Journal of Neurology.

PLEASE NOTE: This web seminar is being hosted by the Parkinson’s Disease Foundation, and registration will be handled through their website, www.pdf.org.
Questions about registration? Call the PDF at 800-457-6676.
Questions about CEUs? Call ASA at 415-974-9628.
Have technical issues? Call NetBriefings at 866-225-1532.